Mineral Bone Disorders in Kidney Transplantation

Semin Nephrol. 2021 Mar;41(2):168-179. doi: 10.1016/j.semnephrol.2021.03.011.

Abstract

Bone disease after kidney transplantation is associated with an increased risk of fractures, morbidity, and mortality. Its pathophysiology is complex, involving multiple contributors including pretransplant bone disease, immunosuppressive medications, and changes in the parathyroid-bone-kidney axis. Risk scores, bone turnover markers, and noninvasive imaging modalities are only able to partially predict the fracture risk in kidney transplant recipients. The optimal management of bone disease after kidney transplantation has not yet been established, with only a limited number of randomized clinical trials evaluating the efficacy of treatment regimens in kidney transplant recipients. This review focuses on the pathophysiology, evaluation, prevention, and treatment of post-kidney transplant mineral and bone disease as guided by recent evidence.

Keywords: Kidney transplant; MBD; fracture; mineral bone disorder; osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bone Density
  • Bone Diseases* / etiology
  • Fractures, Bone*
  • Humans
  • Kidney Transplantation*
  • Minerals

Substances

  • Minerals